More answers like this
GPT-5Sep 15, 2026openai/gpt-5-2025-08-07
Should AI development be paused or restricted?
Short answer: broad, indefinite pauses aren’t a good default. Targeted, capability-based restrictions with time‑bounded pause “circuit breakers” when specific risk thresholds are hit make more sense.
How to think about it
•Separate development from deployment: keep pushing research (especially on safety), while gating deployment and public access for models that cross risk thresholds.
•Regulate by capability and use, not just by model size: focus on bio, cyber, chemical, autonomy/replication, and high‑impact persuasion capabilities.
When a pause is justified
•Time‑limited moratoria, triggered when any of these are credibly demonstrated in evals or incidents:
•Autonomous replication or system-to-system propagation without oversight.
•Step‑change bio or cyber offense (e.g., reliable assistance to design novel pathogens; end‑to‑end intrusion chains with minimal human input).
•Robust deception/persuasion that measurably manipulates real‑world groups at scale.
•Safety controls lag behind capability (no workable containment or monitoring).
•Noncompliance with mandated audits or incident reporting.
•Pauses should have clear exit criteria, milestones, and independent verification.
What restrictions make sense now
•Mandatory pre‑deployment evaluations for frontier models, run by independent labs, covering bio/cyber misuse, autonomy, tool use, and persuasion.
•Tiered access:
•Open weights/data for low‑risk models.
•API‑only access with identity/rate limits and use‑case review for medium risk.
•No public release of weights or restricted partnerships only for high risk.
•Compute and training governance:
•Registration and auditing of very large training runs; secure logging of training data provenance; strong security for model weights.
•Licensing for training above a compute threshold; export and supply‑chain controls for specialized accelerators when linked to risky projects.
•Deployment safeguards:
•Red‑teaming, adversarial testing, and continuous post‑deployment monitoring.
•Usage controls (rate limits, sandboxed tool access, geofencing for sensitive tools), plus content filters and abuse detection.
•Incident response and recall mechanisms; aviation‑style, blameless reporting with legal protections.
•Sector rules where stakes are high (healthcare, finance, critical infrastructure, education, elections): require domain‑specific certification, human oversight, and liability clarity.
•Transparency and accountability:
•Public model and system cards with evaluated capabilities and limitations.
•Corporate governance that gives safety teams authority and board‑level accountability; penalties for negligent deployment.
Why not a blanket pause
•It would entrench incumbents, push work underground or offshore, and slow safety research alongside capability research.
•We’d forgo real benefits (medicine, accessibility, science) while still bearing risks from actors who won’t pause.
Bottom line
•Don’t freeze the field; do enforce strong guardrails, independent evaluations, graduated access, and conditional, time‑boxed pauses when concrete risk triggers are met.
If you’re weighing this for a policy, company practice, or a debate, tell me your context and audience—I can tailor a one‑page brief or talking points.